(MENAFN- GlobeNewsWire - Nasdaq) Innovations in bioabsorbable materials, 3D-printed implants, and surgical tech enhance treatment of facial injuries and deformities globally. North America leads while Asia-Pacific shows rapid growth.Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Craniomaxillofacial (CMF) Devices Market - Products, Materials and Applications" has been added to ResearchAndMarkets.com's offering.
The craniomaxillofacial (CMF) devices market is witnessing robust growth due to advances in medical technology and heightened demand for facial reconstruction. The market is projected to expand from an estimated $2.1 billion in 2024 to $3.5 billion by 2030, with an impressive CAGR of 8.7% during this period.
Factors such as rising numbers of cranial and maxillofacial injuries from road accidents, sports, and violence are key market drivers. Awareness of congenital disorders like cleft lips and certain skull malformations further supports demand for CMF solutions. Additionally, technological advancements in minimally invasive procedures and robotic-assisted surgeries are enhancing outcomes and expanding market reach.
Other factors, including increasing osteoporosis cases among the elderly and the demand for aesthetic surgeries, further amplify the market's growth. The trend towards improved healthcare access, especially in emerging regions, underpins market expansion, supported by initiatives from organizations like the American Society of Craniofacial Surgeons.
Regional Insights on the Craniomaxillofacial Devices Market
North America leads the CMF devices market, accounting for an estimated 53% share in 2024. This leadership is attributed to the region's high incidence of facial deformities, a strong healthcare infrastructure, and substantial expenditure on healthcare. The availability of state-of-the-art implants and a high volume of CMF procedures contribute to sustained growth. In contrast, Asia-Pacific is poised to be the fastest-growing market with a CAGR of 9.8% from 2024 to 2030. Key contributors include advancements in healthcare systems, rising income levels, and a burgeoning geriatric demographic, alongside increased demand for innovative surgical methods.
Product-Specific Trends in the Craniomaxillofacial Devices Market
The CMF devices market segments include CMF plate and screw fixation, cranial flap fixation devices, distraction systems, bone graft substitutes, TMJ replacements, and thoracic fixation devices. In 2024, the CMF Plate and Screw Fixation segment is projected to dominate with a 65.3% market share due to its widespread surgical applications. Bone graft substitutes are anticipated to grow fastest, with a 10.2% CAGR from 2024 to 2030, driven by the scarcity of donor bones and the need for innovative bone reconstruction materials.
Material-Specific Insights on Craniomaxillofacial Devices
By material, the market divides into metal, bioabsorbable materials, ceramics, and plastics. Metal leads the market with a 62.2% share in 2024, valued for its strength and durability in CMF procedures. Titanium and its alloys, noted for their biocompatibility and resistance, are predominantly used for implants. Bioabsorbable materials are set to grow rapidly with a 10.9% CAGR as they eliminate the need for additional surgeries, enhancing market acceptance.
Applications Driving the CMF Devices Market
Within application categories, orthognathic and dental surgeries dominate with a 51.8% share in 2024, largely due to their role in correcting dental anomalies. Meanwhile, neurosurgery and ENT segments are projected for highest growth, with a 9.5% CAGR from 2024 to 2030, thanks to increased cases of trauma and advancements in surgical methods. Enhanced surgical technologies and bioabsorbable implant developments support ongoing market expansion.
Report Scope
This global analysis of the CMF devices market covers the period 2021-2030, focusing on diverse geographies, products, materials, and applications. It provides industry insights, company profiles, and details on recent developments, offering a thorough understanding of market advancements and future projections.
Historical Period: 2021-2023 Base Year: 2024 Forecast Period: 2025-2030 Market Valuation: USD Companies Analyzed: 17 Acumed LLC Avinent Implant System, S.L.U. B. Braun Melsungen AG Biotech Orthomed Inc. Biocomposites Ltd. Changzhou XC Medico Technology Co., Ltd. Integra LifeSciences Holdings Corporation Johnson & Johnson MedTech KLS Martin SE & Co. KG Matrix Surgical USA Medartis AG Medtronic plc Meticuly Co. Ltd. Renishaw plc Stryker Corporation Xilloc Medical Int B.V. Zimmer Biomet Holdings, Inc.
Key Attributes
CONTACT:
CONTACT:
Laura Wood,Senior Press Manager
...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment